The 13-valent pneumococcal conjugated vaccine introduction in subjects aged >50 years: the result of a Health Technology Assessment

F Kheiraoui, Chiara De Waure, Maria Lucia Specchia, Maria Luisa Di Pietro, L Mantovani, Silvio Capizzi, Chiara Cadeddu, Francesco Di Nardo, Anna Maria Ferriero, Maria Assunta Veneziano, G Furneri, Gualano, N Nicolotti, A Sferrazza, Pietro Refolo, Maria Daniela Gliubizzi, R Saulle, G La Torre, Arturo Ricciardi

Research output: Contribution to journalConference article

Abstract

Nessuno
Original languageEnglish
Pages (from-to)284-284
Number of pages1
JournalEuropean Journal of Public Health
Volume23
Publication statusPublished - 2013
Event6th European Public Health Conference “Health in Europe: are we there yet? Learning from the past, building the future” - Bruxelles
Duration: 13 Nov 201316 Nov 2013

Keywords

  • 13-valent Pneumococcal Vaccine
  • Health Technology Assessment

Fingerprint

Dive into the research topics of 'The 13-valent pneumococcal conjugated vaccine introduction in subjects aged >50 years: the result of a Health Technology Assessment'. Together they form a unique fingerprint.

Cite this